Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tau PET Imaging in NOMEM With 18F-MK6240
NCT03389100Phase 2Enrolling by invitation
- Sponsor
- Columbia University
- Start
- Jul 2018
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of florquinitau, sponsored by Columbia University. Started Jul 2018; status: enrolling by invitation.
02
Drugs
florquinitau
Beyond the preview
Go deeper on NCT03389100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389100.